Several studies have demonstrated that n-6 DPA is also retro-converted to arachidonic acid AA in rats 13 15 , however, retro-conversion of DPAs is not fully understood. Importantly, there is a lack of information of the conversion properties in several human cell lines established from different tissues and blood, fatty acid metabolism broadly varies between different cell lines depending on the physiological cell functions. To understand the health benefits of n-3 DPA and n-6 DPA, better characterization of their metabolism in multiple cell lines, and comparing their conversion to EPA, DHA and AA. The aim of current study was to clarify the bioconversion of DPAs in three human cell lines Caco-2, HepG2, and THP-1, derived from colon, liver, and monocytes.
Gibco Grand Island, NY, USA .
Cell culture
Caco-2 human colon carcinoma cell line , HepG2 human hepatoblastoma cell line and THP-1 human monocytic leukemia cell line were obtained from DS Pharma Biomedical Suita, Osaka, Japan . Caco-2 cells were cultured in MEM with 1 nonessential amino acid, 10 FBS, 100 U/mL penicillin and 100 μg/mL streptomycin. HepG2 and THP-1 cells were cultured in DMEM and RPMI 1640, respectively, with 10 FBS, 100 U/mL penicillin and 100 μg/mL streptomycin. Cells were incubated at 37 in a humidified atmosphere containing 5 CO 2 . After 48 h pre-incubation, media were replaced with fresh media containing n-3 DPA or n-6 DPA for 72 h. Fatty acids were added to the culture media as ethanol solutions, and control cells were treated with ethanol alone. The final concentration of ethanol was 0.1 in all culture media, and no cytotoxicity was observed.
Extraction and separation of cellular lipids
After incubation, cells were washed three times with phosphate buffered saline PBS and centrifuged at 115 x g to recover. Total lipid was extracted from the cells, as described previously by Bligh and Dyer 16 . To separate the neutral lipid NL and phospholipid PL fractions, total lipids were applied to a Sep-Pak Plus Silica Cartridge Waters, Milford, MA, USA . The NL were eluted with a chloroform/methanol 97:3 v/v and PL were subsequently eluted with methanol.
Fatty acid analysis
The fatty acid compositions of cellular lipids were determined by gas chromatography GC after preparation of methyl ester derivatives as previously described 17 . The GC analysis was performed using a Shimadzu GC-2014 equipped with a flame-ionization detector FID and a capillary column Omegawax-320 30 m 0.32 mm i.d.: Supelco, Bellefonte, PA, USA . The temperatures of the detector, injector, and column were 260, 250 and 200 , respectively. The carrier gas, helium was flown at 50 kPa. Each fatty acid was identified based on the retention times of authentic standards. Fatty acid composition was expressed as weight percentage of total fatty acids.
Cellular protein content
After washing with PBS three times, cells were centrifuged at 115 x g to recover. Cells were lysed with cold RIPA buffer 20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM Na 3 VO 4 , 2.5 mM sodium pynophosphate, 0 . 0 1 p h e n y l m e t h y l s u l f o n y l f l u o r i d e , 1 m M β-glycelphophate, 1 TritonX-100, and protease inhibitor cocktail Sigma Chemical Co. St. Louis, MO . Cell lysates were centrifuged at 18,400 x g for 30 min at 4 . Protein concentration was measured using a DC protein assay kit Bio-Rad Laboratories, Hercules, CA .
Statistical Analysis
All values are expressed as means SE n 3 . Analysis of variance was used to test for significant differences between different groups. Statistical difference was determined by the Scheffe s F test or Student s t test at p 0.05 or p 0.01.
RESULTS

Fatty acid composition of cellular lipids in Caco-2,
HepG2, and THP-1 cells treated with n-3 DPA After incubation of Caco-2 cells in culture media containing 25-75 μM n-3 DPA for 72 h, the fatty acid composition of the total lipids was determined by GC-FID. n-3 DPA in fatty acid composition increased in a dose-dependent manner, reaching 18.89 1.66 with 75 μM treatment Fig.  1 . In addition, EPA also significantly increased to 10.93 0.31 with 75 μM n-3 DPA, increasing from 0.37 0.01 in control cells, whereas DHA levels did not change. Additionally, we observed significant decreases in 16:1, 18:1n-9 and AA following treatment with n-3 DPA.
Similar to Caco-2 cells, HepG2 cells treated with 75 μM n-3 DPA for 72 h showed a marked increase in both EPA and n-3 DPA 1.89 0.52 μg/cell protein in the control cells. However, the DHA composition decreased following 75 μM n-3 DPA treatment. Similar to n-3 DPA-treated Caco-2 cells, the amount of AA, 16:1 and 18:1n-9 significantly decreased. Taken together, we observed retro-conversion of n-3 DPA to EPA in all three human cell lines, Caco-2, HepG2, and THP-1, whereas desaturation to DHA was cell line dependent.
Fatty acid composition of NL and PL in HepG2 cells
treated with n-3 DPA After incubation of HepG2 cells with 75 μM n-3 DPA for 72 h, NL and PL were separated from the total lipid fraction, and the fatty acid composition of each lipid class was analyzed. In the control cells, EPA, n-3 DPA, and DHA were present at very low levels in NL. Following treatment with n-3 DPA, we observed increases in all three fatty acids, particularly of n-3 DPA, which increased to 3.60 1.16 of NL Fig. 3a . In the PL fraction, the EPA composition increased from 0.33 0.04 in the control cells to 3.96 0.07 in n-3 DPA-treated cells. EPA levels were comparable to n-3 DPA and DHA in the PL of HepG2 cells treated with n-3 DPA Fig. 3b . In contrast to the PL fraction, the NL fraction of n-3 DPA-treated cells was low ratio of EPA 0.40 0.04 compared to n-3 DPA. These data suggest that the EPA converted from n-3 DPA accumulates in the PL, but not the NL.
Fatty acid composition of cellular lipids in Caco-2,
and HepG2 cells treated with n-6 DPA We analyzed the fatty acid composition of Caco-2 and HepG2 cells following 72 h incubation with 75 μM of n-6 DPA, a structural isomer of n-3 DPA. Treatment with n-6 DPA resulted in significantly increased levels of AA and n-6 DPA in both cell lines, whereas EPA, n-3 DPA and DHA did not change in either cell line Fig. 4 . In Caco-2 cells, n-6 DPA-treatment resulted in elevated AA and n-6 DPA levels, with AA increasing from 4.84 0.10 to 8.38 0.34 , and n-6 DPA increases from undetectable in controls to 17.57 3.01 Fig. 4a . In contrast, 16:1 and 18:1n-9 levels were markedly decreased following n-6 DPA treatment. These data show that similar to n-3 DPA, n-6 DPA was converted to AA in Caco-2 and HepG2 cells.
DISCUSSION
n-3 DPA is an intermediate product in the metabolic pathway that converts EPA to DHA. Recently, nutraceutical functions of n-3 DPA have been brought into focus, as it is a dietary n-3 fatty acid contained in sea foods, such as salmon and abalone. Several studies have found health benefits of n-3 DPA that compare with EPA and DHA in cell cultures 6 and rodents 18, 19 . In addition, n-3 DPA and n-6 DPA derived 7, 8, 17-trihydroxy-9, 11, 13, 15E, 19Z-docosapentaenoic acid RvD1 n-3 DPA , 7, 14-dihydroxy-8, 10, 12, 16Z, 19Z-docosapentaenoic acid MaR1 n-3 DPA , 17S -hydroxy-docosapentaenoic acid and 10,17S -dihydroxydocosapentaenoic acid have been identified as specialized pro-resolving mediators 20, 21 . AA, which is a retro-conversion product of n-6 DPA, is an important fatty acid for cell membrane PLs, and is derived to eicosanoids, which perform physiological functions 22 . It is therefore important to investigate the metabolism of n-3 DPA and n-6 DPA to elucidate the molecular mechanisms of their beneficial health functions. In previously reported studies, n-3 DPA was found to convert to EPA and DHA in the rat liver 7 .
Retro-conversion of n-6 DPA was also reported in rat hepatocytes 23 . However, the bioconversion profiles of DPAs have not been compared between several human cell lines established from different tissues and blood. In the present study, addition of n-3 DPA to the culture media increased both EPA and n-3 DPA in Caco-2, HepG2, and THP-1 cells. The increase in EPA was greater in Caco-2 and THP-1 cells than in HepG2 cells. In contrast, an increase in DHA was observed only in HepG2 cells. These results indicate that n-3 DPA bioconversion to EPA and DHA varies between human cells lines from different tissues and blood.
We also analyzed the n-3 DPA, EPA, and DHA composition of PL and NL fractions. In HepG2 cells treated with n-3 DPA, EPA was increased levels comparable to n-3 DPA and DHA in the PL fraction. The increase in EPA was more remarkable in the PL than in the NL fraction, whereas additional n-3 DPA was similarly incorporated into both PL and NL fractions. Holub et al. 24 reported EPA and n-3 DPA incorporated PL pools in the liver of young rats. Esterification of n-3 PUFAs in the PL plays critical roles for biological functions 25 . On the other hand, intracellular NL, particularly triacylglycerol, are mainly accumulated as an energy source for β-oxidation, which is a reaction consisting of two carbon chain-shortening as the retro-conversion of n-3 DPA to EPA. However, because EPA converted from n-3 DPA predominantly accumulated in the PL, retro-conversion products might to play an important role for specific biological functions rather than being used as a fatty acid substrate for energy production. In Caco-2, HepG2, and THP-1 cells treated with n-3 DPA, 16:1 and 18:1n-9 contents decreased compared to control cells. In addition, down-regulation of mRNA expression of stearoyl-CoA desaturase was also observed in HepG2 cells treated with n-3 DPA data not shown . These data shows n-3 DPA treatment regulates intracellular 16:1 and 18:1n-9 contents in human cell lines.
Retro-conversion of n-6 DPA has been reported to occur in rat liver and testis 13 15 . In the present study, n-6 DPA was converted to AA in Caco-2 and HepG2 cells. Further, AA and n-6 DPA levels were also higher in the fatty acid composition of Caco-2 cells than HepG2 cells. In the retroconversion of n-6 DPA to AA, chain-shortening and further saturation reaction take place. However, 20:5n-6 and 22:4n-6 were not detected in this study. In addition, the enzymes involved and the physiological significance of n-6 DPA retro-conversion remains unclear. Better understanding of the metabolism of DPAs and their retro-conversions, with respect to mechanisms and contributions to our health and disease, is worthy of further investigation.
CONCLUSION
In this study, we investigated the bioconversion of n-3 and n-6 DPAs in three different human cell lines. n-3 DPA retro-converted to EPA in Caco-2, HepG2, and THP-1 cells. However, DHA from n-3 DPA was only observed in HepG2 cells. n-6 DPA was also retro-converted to AA in Caco-2 and HepG2 cells. EPA and AA accumulated in the fatty acids of Caco-2 cells to a greater extent than in HepG2 cells. Further, the increase in EPA due to the retro-conversion of n-3 DPA treatment was more remarkable in PL than in NL.
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